Avisa Diagnostics Inc. (FOGCF) Research

Avisa Diagnostics Inc. is a medical device company currently in its clinical development phase. The company is advancing the Avisa BreathTest, an innovative drug-device biomarker platform. This technology enables the exceptionally rapid identification and quantitative monitoring of virulent bacterial pathogens, activated when patients inhale or ingest its proprietary diagnostic compounds. Avisa Diagnostics has successfully established clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and community-acquired pneumonia. Currently, the firm is concentrating its efforts on pivotal trials addressing Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is headquartered in Santa Fe, New Mexico.

Market snapshot

Symbol
FOGCF
Price
$0.00
Day change
0.00%
Market cap
$87.2K
P/E ratio
-0.23x
52-week range
0.000001-0.00001
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF)
  • Basilea Pharmaceutica AG (BPMUF)
  • PolyNovo Limited (CALZF)
  • Elite Pharmaceuticals, Inc. (ELTP)
  • ManifestSeven Holdings Corporation (MNFSF)
  • Swedencare AB (publ) (SWDCF)
  • Torii Pharmaceutical Co., Ltd. (TRXPF)
  • Tsuruha Holdings Inc. (TSUSF)

Open Avisa Diagnostics Inc. (FOGCF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.